University of Delaware, Department of Biological Sciences, Newark, DE 19716, USA.
Bone. 2012 Aug;51(2):224-31. doi: 10.1016/j.bone.2011.11.012. Epub 2011 Dec 2.
Increased proteoglycan (PG) synthesis is essential for the stimulation of cartilage repair processes that take place during the reversible phase of osteoarthritis (OA). In articular cartilage, xylosyltransferase 1 (Xylt1) is the key enzyme that initiates glycosaminoglycan (GAG) chain synthesis by transferring the first sugar residue to the PG core protein. Biological activity of PGs is closely linked to GAG biosynthesis since their polyanionic nature directly contributes to the proper hydration and elastic properties of the cartilage tissue present at the articular interface. The aim of this study was to investigate whether variations in the level of Xylt1 present in serum can be used to predict OA disease progression. The influence of bone forming activity on the systemic release of this enzyme was addressed by experimentally-inducing OA in mice of two different genetic backgrounds that were previously characterized for their distinct bone metabolism: C57BL/6J (B6, high bone remodelers) or C3H/HeJ (C3H, high bone formers). Serum was collected after medial meniscectomy or sham surgeries in young adult mice of these two strains over a period of 3.5months at which point knee histopathology was assessed. A significant increase in serum Xylt1 levels observed shortly after meniscectomy positively correlated with severe cartilage damage evaluated by histological assessment at later time points in mice of the C3H background. In contrast, no temporal regulation of Xylt1 level was found between meniscectomies and control surgeries in B6 mice, which developed OA at a slower rate. Additionally, longitudinal evaluation of the serum levels of other markers of cartilage/bone metabolism (C1,2C, osteocalcin) did not reveal any association with late knee damages. Our results strongly support the idea that serum Xylt1 has a clinical value for monitoring risk of OA progression in young adults with high bone forming potential. Ultimately, the understanding of posttraumatic mechanisms regulating PG synthesis and their modification by GAG will be essential so that interventions that stimulate cartilage regrowth can be undertaken prior to irreversible destruction of the joint tissue. This article is part of a Special Issue entitled "Osteoarthritis".
蛋白聚糖(PG)合成增加对于发生在骨关节炎(OA)可逆阶段的软骨修复过程的刺激至关重要。在关节软骨中,木糖基转移酶 1(Xylt1)是通过将第一个糖残基转移到 PG 核心蛋白上来启动糖胺聚糖(GAG)链合成的关键酶。PG 的生物学活性与 GAG 生物合成密切相关,因为其聚阴离子性质直接有助于关节界面处软骨组织的适当水合和弹性特性。本研究旨在探讨血清中存在的 Xylt1 水平的变化是否可用于预测 OA 疾病进展。通过在两种具有不同骨代谢特征的遗传背景的小鼠中实验性诱导 OA,研究了骨形成活性对这种酶的系统性释放的影响:C57BL/6J(B6,高骨重塑者)或 C3H/HeJ(C3H,高骨形成者)。在这两种品系的年轻成年小鼠中,在进行内侧半月板切除术或假手术后的 3.5 个月期间收集血清,并在此期间评估膝关节组织病理学。在 C3H 背景的小鼠中,在半月板切除术后不久观察到的血清 Xylt1 水平的显著增加与通过组织学评估在稍后时间点评估的严重软骨损伤呈正相关。相比之下,在 B6 小鼠中,在半月板切除术和对照手术之间未发现 Xylt1 水平的时间调节,B6 小鼠的 OA 发展速度较慢。此外,对软骨/骨代谢的其他标志物(C1、2C、骨钙素)的血清水平进行的纵向评估并未显示出与晚期膝关节损伤有任何关联。我们的研究结果强烈支持这样一种观点,即血清 Xylt1 对于监测具有高骨形成潜力的年轻成年人 OA 进展的风险具有临床价值。最终,了解调节 PG 合成的创伤后机制及其被 GAG 修饰的机制对于进行能够在关节组织不可逆破坏之前刺激软骨再生的干预措施至关重要。本文是一个特刊的一部分,该特刊题为“骨关节炎”。